Vasoactive Peptides- Inhibitors and HF Flashcards
-PRIL
ACEI
captopril
enalapril
lisinopril
ACEI indication
-PRIL
Primary HTN (1st line) Heart Failure (HFrEF) -1st Line, all stages-- REDUCES MORTALITY
Acute MI
Chronic Renal disease
ACEI MOA
-PRIL
Bind ACE [bradykinin]
Prevent angiotensin I conversion
Preload/Afterload
Ventricular Remodeling
ACEI contraindications
-PRIL
pregnancy,bilateral renal stenosis
ACEI AE
-PRIL
Cough (if this bothers patient, consider switching to an AT1 Receptor Blocker)
-SARTAN
AT1 receptor blockers (ARB)
losartan
valsartan
ARB MOA
-sartan
Prevent Angiotensin II activity
*no effect on [bradykinin]
Preload/Afterload
Ventricular Remodeling
ARB indication
-sartan
Primary HTN
Heart Failure
ARB contraindications
-sartan
Contraindications – pregnancy, bilateral renal stenosis
Endothelin Receptor Antagonists
-SENTAN
bosentan
ambrisentan
Endothelin Receptor Antagonists MOA
Restores balance between Eta & prostaglandins
Endothelin Actions: vasoconstriction, + inotrope/chronotrope, vascular/myocardial hypertrophy, bronchoconstriction
Eta/prostaglandins Contraction & proliferation
AE: hypotension/edema, palpitations,
Endothelin Receptor Antagonists indications
Pulmonary Arterial HTN
Endothelin Receptor Antagonists AE
requires liver monitoring
contraindication in pregnancy!
Natriuretic peptide agonists indication
Nesiritide
acute decompensated HF
Natriuretic peptide agonists MOA
ANP/BNP metabolism inhibitor
Recombinant human BNP
Preload & Afterload (vasodilation)
Natriuretic Peptide function: Vasodilation, suppress RAAS ( vasoconstrictors), GFR, renin release